COVID-19 Vaccination, Treatment Recommendations and Special Considerations for Gynecologic Cancer Patients

The landscape of gynecologic cancer care changed dramatically over the course of the COVID-19 pandemic, caused by the SARS-CoV-2 coronavirus. Whether due to a compromised immune system from chemotherapy or potentially altered immune response with new cancer therapies, patients with gynecologic cancer have specific considerations in timing and use of vaccines and monoclonal antibodies.